Actavis to acquire pharmaceutical company Durata Therapeutics

The U.S. Federal Trade Commission has cleared the Actavis proposal to acquire pharmaceutical company Durata Therapeutics, according to a PBRHome report.

Advertisement

Actavis has a broad pharmaceuticals portfolio in areas including gastroenterology, women’s health, urology and more. The company operates more than 30  manufacturing and distribution facilities.

More articles on gastroenterology:
5 must-reads for the forward-thinking gastroenterology leader
Dr. Lawrence Kosinski: 4 thoughts on the future of gastroenterology
EndoChoice considers $100M+ IPO

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.